News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
152 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33091)
2026 (14576)
Month
January (2433)
February (2866)
March (3029)
April (3116)
May (3132)
Day
1 (117)
2 (174)
3 (44)
5 (18)
6 (63)
7 (148)
8 (162)
9 (80)
10 (92)
12 (11)
13 (86)
14 (145)
15 (167)
16 (131)
17 (117)
19 (12)
20 (203)
21 (171)
22 (152)
23 (182)
24 (89)
26 (24)
27 (111)
28 (193)
29 (219)
30 (205)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
Day
1
2
3
5
6
7
8
9
10
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Press Releases
Foghorn Therapeutics Presents New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and for Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting
April 22, 2026
·
6 min read
Press Releases
Immuneering to Present New Survival Data from First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP in an Oral Presentation at the 2026 ASCO Annual Meeting
April 22, 2026
·
5 min read
Press Releases
Belite Bio Initiates Rolling Submission of New Drug Application to the U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease
April 22, 2026
·
5 min read
Press Releases
Inhibrx Provides Clinical Update on Ozekibart (INBRX-109) in Late Line Colorectal Cancer
April 22, 2026
·
9 min read
Press Releases
Olema Oncology to Present Initial Clinical Data for OP-3136 at the 2026 ASCO Annual Meeting
April 22, 2026
·
5 min read
Press Releases
Bicycle Therapeutics Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting
April 22, 2026
·
3 min read
Press Releases
Vapotherm® Announces FDA 510(k) Clearance for the All Patient Circuit™, Enabling High Velocity Therapy for Neonatal to Adult Patients
April 22, 2026
·
2 min read
Press Releases
Cytokinetics to Announce First Quarter Results on May 5, 2026
April 22, 2026
·
3 min read
Press Releases
OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026
April 22, 2026
·
1 min read
Press Releases
TransMedics to Report First Quarter 2026 Financial Results on May 5, 2026
April 22, 2026
·
1 min read
Previous
4 of 16
Next